Literature DB >> 19874459

The plasma von Willebrand factor O-glycome comprises a surprising variety of structures including ABH antigens and disialosyl motifs.

K Canis1, T A J McKinnon, A Nowak, M Panico, H R Morris, M Laffan, A Dell.   

Abstract

BACKGROUND: von Willebrand factor (VWF) is a key component for maintenance of normal hemostasis. Its glycan moieties, accounting for about 20% of its molecular weight, have been shown to affect many of its properties. Previous studies reported correlations between VWF secretion, half-life and the nature or presence of its N-glycans, and more importantly between VWF plasma level and the type of N-linked ABH antigens. Despite the presence of 10 predicted O-glycosylation sites, the O-glycome remains poorly characterized, impairing the complete elucidation of its influence on VWF functions. So far only a single glycan structure, a disialyl core 1 glycan, has been identified.
OBJECTIVES: To define an exhaustive profile of the VWF O-glycan structures to help the understanding of their role in VWF regulation and properties.
METHODS: Plasma-derived VWF O-linked sugars were isolated and analyzed using state-of-the-art mass spectrometry methodologies. RESULTS AND
CONCLUSIONS: We provide here a detailed analysis of the human plasma-derived VWF O-glycome. Eighteen O-glycan structures including both core 1 and core 2 structures are now demonstrated to be present on VWF. Amongst the newly determined structures are unusual tetra-sialylated core 1 O-glycans and ABH antigen-containing core 2 O-glycans. In conjunction with current models explaining VWF activity, knowledge of the complete O-glycome will facilitate research aimed at providing a better understanding of the influence of glycosylation on VWF functions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19874459     DOI: 10.1111/j.1538-7836.2009.03665.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  28 in total

1.  Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein/amyloid beta-peptides in human cerebrospinal fluid.

Authors:  Adnan Halim; Gunnar Brinkmalm; Ulla Rüetschi; Ann Westman-Brinkmalm; Erik Portelius; Henrik Zetterberg; Kaj Blennow; Göran Larson; Jonas Nilsson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-28       Impact factor: 11.205

2.  Factor VIII and von Willebrand factor are ligands for the carbohydrate-receptor Siglec-5.

Authors:  Julie N Pegon; Mohamad Kurdi; Caterina Casari; Soline Odouard; Cécile V Denis; Olivier D Christophe; Peter J Lenting
Journal:  Haematologica       Date:  2012-06-24       Impact factor: 9.941

Review 3.  Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A.

Authors:  Steven W Pipe; Robert R Montgomery; Kathleen P Pratt; Peter J Lenting; David Lillicrap
Journal:  Blood       Date:  2016-09-01       Impact factor: 22.113

4.  Glycosylation sterically inhibits platelet adhesion to von Willebrand factor without altering intrinsic conformational dynamics.

Authors:  Alexander Tischer; Venkata R Machha; Laurie Moon-Tasson; Linda M Benson; Matthew Auton
Journal:  J Thromb Haemost       Date:  2019-09-03       Impact factor: 5.824

Review 5.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2009-2010.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2014-05-26       Impact factor: 10.946

6.  Distinct human α(1,3)-fucosyltransferases drive Lewis-X/sialyl Lewis-X assembly in human cells.

Authors:  Nandini Mondal; Brad Dykstra; Jungmin Lee; David J Ashline; Vernon N Reinhold; Derrick J Rossi; Robert Sackstein
Journal:  J Biol Chem       Date:  2018-03-28       Impact factor: 5.157

7.  A discontinuous autoinhibitory module masks the A1 domain of von Willebrand factor.

Authors:  W Deng; Y Wang; S A Druzak; J F Healey; A K Syed; P Lollar; R Li
Journal:  J Thromb Haemost       Date:  2017-08-09       Impact factor: 5.824

8.  An Insight into Glyco-Microheterogeneity of Plasma von Willebrand Factor by Mass Spectrometry.

Authors:  Ebtesam A Gashash; Arya Aloor; Dong Li; He Zhu; Xiao-Qian Xu; Cong Xiao; Junping Zhang; Aishwarya Parameswaran; Jing Song; Cheng Ma; Weidong Xiao; Peng George Wang
Journal:  J Proteome Res       Date:  2017-07-27       Impact factor: 4.466

9.  High Performance IT-MS Sequencing of Glycans (Spatial Resolution of Ovalbumin Isomers).

Authors:  Jenny Jiao; Hailong Zhang; Vernon N Reinhold
Journal:  Int J Mass Spectrom       Date:  2011-06-01       Impact factor: 1.986

Review 10.  The molecular characterization of von Willebrand disease: good in parts.

Authors:  P D James; D Lillicrap
Journal:  Br J Haematol       Date:  2013-02-14       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.